Use
AssigneeDupont Nutrition Biosciences Aps
InventorNina Rautonen
Life of this patent
Estimating the term…
Loading patent…
AssigneeDupont Nutrition Biosciences Aps
InventorNina Rautonen
Estimating the term…
Use of at least one strain of a microorganism and/or a metabolite thereof in the manufacture of a support for administration to a subject for modulating satiety signalling, wherein the support is a pharmaceutically acceptable support or a food product. Suitably, the at least one strain of a microorganism and/or a metabolite thereof may be administered to the subject for the treatment and/or prevention of excess weight and/or a disease caused by excess weight. Likewise, the at least one strain of a microorganism and/or a metabolite thereof is administered to the subject for the treatment and/or prevention of obesity and/or a caused by obesity. Preferably, the microorganism is a probiotic microorganism. Suitably the microorganism may be a lactic acid bacterium. Li one embodiment the microorganism is a strain of Lactobacillus spp. and/or Bifidobacterium spp., for example a strain of Lactobacillus acidophilus, L. curvatus, L. salivarius and/or B. lactis.
Use of at least one strain of a microorganism and/or a metabolite thereof in the manufacture of a support for administration to a subject for modulating satiety signalling.
Use of at least one strain of a microorganism and/or a metabolite thereof in the manufacture of a support for administration to a subject for inducing satiety.
A method of modulating satiety signalling in a subject which method comprises administering to the subject an effective amount of at least one strain of a microorganism and/or a metabolite thereof.
A method for selecting a microorganism and/or a metabolite thereof to prepare a support for administration to a subject for inducing satiety and/or treating excess weight, including obesity, wherein the method comprises the steps of:
-42. (canceled)
Dependencies are inferred from the claim text.